Incidence and predictors of target lesion failure in a multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all-comers registry

Rajiv Ananthakrishna, William Kristanto, Li Liu, Siew Pang Chan, Poay Huan Loh, Edgar L. Tay, Koo Hui Chan, Mark Y. Chan, Chi Hang Lee, Adrian F. Low, Huay Cheem Tan, Joshua P. Loh

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Objectives: To evaluate the target lesion failure (TLF) rate of the SYNERGY stent in all-comers, multiethnic Asian population. Background: Currently, most drug eluting stents deliver anti-proliferative drugs from a durable polymer which is associated with a risk of late stent thrombosis. The novel everolimus-eluting, platinum chromium SYNERGY stent is coated with a bioabsorbable abluminal polymer that resolves within 4 months. Methods: This was a prospective, single center registry of consecutive patients treated with the SYNERGY stent between December 2012 and April 2015. The primary outcome was the incidence of TLF, defined as the combination of cardiac death, target vessel myocardial infarction, or clinically driven target lesion revascularization (TLR) at 1 year. Results: A total of 807 patients received the SYNERGY stent during the study period. One-year clinical outcome data was available for 765 patients (94.8%) and were considered for statistical analysis. The mean age was 60.7 ± 10.8 years, and 83.4% were males. Patients with acute myocardial infarction consisted of 50.3% (ST-segment elevation myocardial infarction: 23.0%, Non-ST-segment elevation myocardial infarction: 27.3%) of the study population. The treated lesions were complex (ACC/AHA type B2/C: 72.7%). The primary end point of TLF at 1 year was 5.8%. Rates of cardiac mortality, target vessel myocardial infarction, and TLR were 4.2, 1.0, and 1.3%, respectively, at 1 year. Predictors of the incidence and time to early TLF were female gender, Malay ethnicity, diabetes mellitus, acute myocardial infarction at presentation, a prior history of coronary artery bypass surgery and the presence of lesion calcification. The incidence of definite stent thrombosis was 0.4% at 1 year. Conclusions: In this registry, the use of the SYNERGY stent was associated with low rates of TLF at 1 year.

Original languageEnglish
Pages (from-to)1097-1103
Number of pages7
JournalCatheterization and Cardiovascular Interventions
Volume92
Issue number6
DOIs
Publication statusPublished - 15 Nov 2018

Keywords

  • SYNERGY
  • clinical outcomes
  • percutaneous coronary intervention
  • stent
  • target lesion failure

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this